Ticker brief
TENX
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
20
authors 14d
10
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-06-22 → 2026-07-02 · now +0.31 (−1 bearish … +1 bullish)
Who spoke10
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @Brad_E_Schulz | C | · | 4 | +0.20 |
| @Quantumup1 | C | -1.95 | 3 | +0.38 |
| @OptionRunners | C | +1.57 | 3 | +0.30 |
| @Maximus_Holla | C | -0.48 | 3 | +0.50 |
| @BiopharmIQ | B | · | 2 | +0.25 |
| @OptionsFlowBoss | C | · | 1 | +0.45 |
| @semodough | C | -0.75 | 1 | +0.45 |
| @MartyChargin | C | -0.72 | 1 | +0.35 |
| @Greatstockpix | C | -0.61 | 1 | +0.20 |
| @OpenOutcrier | C | · | 1 | +0.40 |
Recent signals20of 20 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-07-02 | @Brad_E_Schulz | +0.15 | Category overview of tracked stocks with sector gainers. | · | tweet ↗ |
| 2026-07-02 | @Brad_E_Schulz | +0.25 | Lists stocks up at least 4% on above-average volume. | · | tweet ↗ |
| 2026-07-02 | @Maximus_Holla | +0.40 | Author praises TENX close. | · | tweet ↗ |
| 2026-07-02 | @BiopharmIQ | +0.25 | Biotech catalyst roundup cites clinical data, approval, FDA news, and financing. | · | tweet ↗ |
| 2026-07-02 | @BiopharmIQ | +0.25 | Biotech midday mover list with catalysts and percentage moves. | · | tweet ↗ |
| 2026-07-02 | @Maximus_Holla | +0.75 | Added more TENX here 14.5 to the run up play — Author says they added more TENX for a run-up play at 14.5. | · | tweet ↗ |
| 2026-07-02 | @Brad_E_Schulz | +0.15 | Intraday category overview with sector returns and gainers. | · | tweet ↗ |
| 2026-07-02 | @Brad_E_Schulz | +0.25 | Intraday list of stocks up at least 4% on elevated volume. | · | tweet ↗ |
| 2026-07-02 | @OpenOutcrier | +0.40 | Tenax gets late-breaking ESC 2026 spot for Phase 3 LEVEL trial data. | · | tweet ↗ |
| 2026-07-02 | @Greatstockpix | +0.20 | Gapper watchlist names six tickers without explicit entries. | · | tweet ↗ |
| 2026-07-02 | @MartyChargin | +0.35 | TENX expects LEVEL Phase 3 topline data in August and ESC late-breaking presentation. | · | tweet ↗ |
| 2026-07-02 | @Maximus_Holla | +0.35 | Tenax expects to report Phase 3 LEVEL topline data in August and present at ESC. | · | tweet ↗ |
| 2026-06-29 | @Quantumup1 | +0.00 | UBS upgrades CYTK to Buy and raises PT to $115 from Neutral/$69. | · | tweet ↗ |
| 2026-06-28 | @semodough | +0.45 | Cantor note argues TENX targets a larger PH-HFpEF market than appreciated, around 4M globally. | · | tweet ↗ |
| 2026-06-26 | @OptionRunners | +0.35 | Reports more call buying in TENX. | · | tweet ↗ |
| 2026-06-26 | @OptionsFlowBoss | +0.45 | Reports bullish positioning detected in TENX. | · | tweet ↗ |
| 2026-06-26 | @OptionRunners | +0.20 | TENX call spreads were added to open interest yesterday. | · | tweet ↗ |
| 2026-06-25 | @OptionRunners | +0.35 | Large TENX call spread opened earlier, pending OI confirmation. | · | tweet ↗ |
| 2026-06-24 | @Quantumup1 | +0.50 | Cantor reiterates Overweight and $35 PT on TENX ahead of 3Q26 Phase 3 data. | · | tweet ↗ |
| 2026-06-22 | @Quantumup1 | +0.65 | Guggenheim reiterated TENX Buy and raised PT to $40 from $34. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.